Company: CORT
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048841
Chunk: 210

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 4
Chunk 210
---
8,481 September 1, 2025 to September 30, 202531 72.32 2,272 Total194 $71.64 $13,895 

(1) In July 2025, we issued 63,175 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 30,862 shares were surrendered to us in satisfaction of related exercise cost and tax obligations. In August 2025, we issued 206,422 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 91,018 shares were surrendered to us. In September 2025, we issued 31,083 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 14,037 shares were surrendered to us.

In July 2025, we issued 33,892 shares of common stock as part of restricted stock vesting, of which 12,126 shares were surrendered to us in satisfaction of related tax obligations. In August 2025, we issued 80,537 shares of common stock as part of restricted stock vesting, of which 28,515 shares were surrendered to us. In September 2025, we issued 51,012 shares of common stock as part of restricted stock vesting, of which 17,387 shares were surrendered to us.

(2) We paid $8.2 million to satisfy the tax withholding obligations associated with the net-share settlement of these cashless option exercises and vesting of restricted stock.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

Not applicable.